Literature DB >> 23772081

Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes.

Sofia de Achaval1, Michael A Kallen, Maureen D Mayes, Maria A Lopez-Olivo, Maria E Suarez-Almazor.   

Abstract

OBJECTIVE: To evaluate the content and construct validity of an individualized patient-reported instrument, the Patient-generated Index (PGI), in patients with systemic sclerosis (SSc), and to compare its performance to that of other instruments and to the Patient-reported Outcomes Measurement Information System (PROMIS) framework.
METHODS: Patients identified the 5 most important life areas affected by SSc, which we categorized into domains of the PROMIS framework (mental, physical, and social). Correlations were obtained between PGI and the Health Assessment Questionnaire (HAQ), the Medical Outcomes Study Short Form-36 (SF-36), and the Symptom Burden Index (SBI) scores.
RESULTS: Sixty-two patients with SSc completed the PGI: 87% women, 69% white, mean age 53 years, mean disease duration 8 years, and 63% with diffuse disease. A total of 258 individual life area responses were recorded: 54% in social health (social function and relationship subcomponents); 28% in physical health (physical function, symptoms, general physical health); and 19% in mental health (consisting largely of the affect subcomponent). Patient PGI responses were categorized into 6 of the 7 subcomponents of the PROMIS framework; substance use/alcohol was not identified. Statistically significant correlations ranging in absolute value from 0.26 to 0.50 were observed between the PGI and the HAQ, SF-36 summary component scores, and the large majority of SF-36 subscales and SBI components.
CONCLUSION: The PGI is a personalized instrument that adequately assessed a wide range of health-related quality of life outcomes within the PROMIS framework. The PGI captured additional constructs not yet defined within the framework that are important for patients with SSc.

Entities:  

Keywords:  PATIENT-CENTERED OUTCOMES; PATIENT-GENERATED INDEX; SCLERODERMA; SYSTEMIC SCLEROSIS

Mesh:

Year:  2013        PMID: 23772081      PMCID: PMC3888061          DOI: 10.3899/jrheum.120978

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  27 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

Authors:  J F Fries; P W Spitz; D Y Young
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

3.  The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis.

Authors:  J L Poole; V D Steen
Journal:  Arthritis Care Res       Date:  1991-03

4.  The impact of pain and symptoms of depression in scleroderma.

Authors:  Lisa M Benrud-Larson; Jennifer A Haythornthwaite; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara White; Fredrick M Wigley
Journal:  Pain       Date:  2002-02       Impact factor: 6.961

Review 5.  Psychologic factors in scleroderma.

Authors:  Jennifer A Haythornthwaite; Leslie J Heinberg; Lynanne McGuire
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

6.  The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis.

Authors:  P Tugwell; C Bombardier; W W Buchanan; C H Goldsmith; E Grace; B Hanna
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

Review 7.  Focus on the individual--quality of life assessments in oncology.

Authors:  Asa Kettis Lindblad; Lena Ring; Bengt Glimelius; Mats G Hansson
Journal:  Acta Oncol       Date:  2002       Impact factor: 4.089

Review 8.  The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Dinesh Khanna; Eswar Krishnan; Esi Morgan Dewitt; Puja P Khanna; Brennan Spiegel; Ron D Hays
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

Review 9.  A review of selected patient-generated outcome measures and their application in clinical trials.

Authors:  Kavita K Patel; David L Veenstra; Donald L Patrick
Journal:  Value Health       Date:  2003 Sep-Oct       Impact factor: 5.725

10.  Self-report questionnaires in five rheumatic diseases: comparisons of health status constructs and associations with formal education level.

Authors:  L F Callahan; W J Smith; T Pincus
Journal:  Arthritis Care Res       Date:  1989-12
View more
  3 in total

1.  Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis.

Authors:  Alexandra B Wiese; Veronica J Berrocal; Daniel E Furst; James R Seibold; Peter A Merkel; Maureen D Mayes; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-11       Impact factor: 4.794

2.  Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis.

Authors:  Tatiana R L Lima; Fernando S Guimarães; Mara N Carvalho; Thaís L M Sousa; Sara L S Menezes; Agnaldo J Lopes
Journal:  Braz J Phys Ther       Date:  2015-03-13       Impact factor: 3.377

3.  Health related quality of life among pregnant women living with HIV in Kenya, results from comparing a patient generated index and the Euroqol 5 dimension 3 level.

Authors:  Jonathan Mwangi; Laura Ternent; Patricia Opondo Awiti Ujiji; Edwin Were; Anna Mia Ekström
Journal:  BMC Womens Health       Date:  2022-03-09       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.